Meeting of the Tick-Borne Disease Working Group, 56964-56965 [2022-20088]
Download as PDF
<![CDATA[
56964
Federal Register / Vol. 87, No. 179 / Friday, September 16, 2022 / Notices
Comments on the ICR must be
received on or before November 15,
2022.
DATES:
Submit your comments to
Sherrette.Funn@hhs.gov or by calling
(202) 795–7714.
FOR FURTHER INFORMATION CONTACT:
When submitting comments or
requesting information, please include
the document identifier 0990–New–60D
and project title for reference, to
Sherrette A. Funn, email:
Sherrette.Funn@hhs.gov, or call (202)
795–7714 the Reports Clearance Officer.
SUPPLEMENTARY INFORMATION: Interested
persons are invited to send comments
regarding this burden estimate or any
other aspect of this collection of
ADDRESSES:
information, including any of the
following subjects: (1) The necessity and
utility of the proposed information
collection for the proper performance of
the agency’s functions; (2) the accuracy
of the estimated burden; (3) ways to
enhance the quality, utility, and clarity
of the information to be collected; and
(4) the use of automated collection
techniques or other forms of information
technology to minimize the information
collection burden.
Title of the Collection: Data
Management Standard Operating
Procedures Survey.
Type of Collection: New.
OMB No.: 0990–New.
Abstract: The Office of the Assistant
Secretary for Health, Office of Research
Integrity is requesting a new approval
from the Office of Management and
Budget of the Data Management
Standard Operating Procedures Survey.
Information from respondents to the
survey will be used to develop a Data
Management Standard Operating
Procedures toolkit that will be
disseminated to researchers, research
administrators, and research institutions
to implement. In addition, other
products will be developed to
disseminate survey results and findings
to include, social media posts, YouTube
video, webinar, and summary report for
the research community.
Likely Respondents: Biostatisticians
and Bioscience Researchers.
ANNUALIZED BURDEN HOUR TABLE
Number of
responses per
respondent
Average
burden
per response
(in hours)
Total
burden hours
Type of respondent
Data Management Standard Operating Procedures Survey.
Biostatisticians and Bioscience Researchers.
1,200
1
45/60
900
Total ...........................................
...........................................................
........................
........................
........................
900
Sherrette A. Funn,
Paperwork Reduction Act Reports Clearance
Officer, Office of the Secretary.
[FR Doc. 2022–20115 Filed 9–15–22; 8:45 am]
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Office of the Secretary
Findings of Research Misconduct;
Correction
Office of the Secretary, HHS.
ACTION: Correction of notice.
AGENCY:
This document corrects errors
that appeared in the notice published in
the August 5, 2022, Federal Register
entitled ‘‘Findings of Research
Misconduct.’’
Applicability Date: The correction
notice is applicable for the Findings of
Research Misconduct notice published
on August 5, 2022.
FOR FURTHER INFORMATION CONTACT: Dr.
Alexander Runko or Ms. Karen Gorirossi
at 240–453–8800.
SUPPLEMENTARY INFORMATION:
SUMMARY:
I. Background
In FR Doc. 2022–16867 of August 5,
2022 (87 FR 48034–48036), there were
errors involving National Institutes of
Health (NIH) grant application UL1
TR000124 affecting six paragraphs on
VerDate Sep<11>2014
16:43 Sep 15, 2022
Jkt 256001
page 48035. The errors are identified
and corrected in the Correction of Errors
section below.
II. Correction of Errors
BILLING CODE 4150–31–P
khammond on DSKJM1Z7X2PROD with NOTICES
Number of
respondents
Form name
Due to additional information
provided by the institution to the Office
of Research Integrity, it was determined
that NIH grant application UL1
TR000124 did not fund or contain
falsified/fabricated data; therefore, this
grant application has been removed
from the findings of research
misconduct reported in FR Doc. 2022–
16867. Thus, in FR Doc. 2022–16867 of
August 5, 2022 (87 FR 48034–48036),
make the following corrections:
1. On page 48035, first column, in FR
Doc. 2022–16867, first paragraph, lines
9–12, remove ‘‘UL1 TR000124
submitted to the National Center for
Advancing Translational Sciences
(NCATS), NIH.’’
2. On page 48035, first column, in FR
Doc. 2022–16867, fourth paragraph,
lines 14–15, remove ‘‘UL TR000124
submitted to NCATS, NIH.’’
3. On page 48035, first column, in FR
Doc. 2022–16867, fifth paragraph, lines
5–6, change ‘‘eleven (11) grant
applications’’ to ‘‘ten (10) grant
applications.’’
4. On page 48035, first column, in FR
Doc. 2022–16867, seventh paragraph,
lines 1–2, and second column, in FR
Doc. 2022–16867, first paragraph, lines
1–3, remove ‘‘UL1 TR000124, ‘UCLA
PO 00000
Frm 00039
Fmt 4703
Sfmt 4703
Clinical and Translational Science
Institute,’ submitted to NCATS, NIH,
Awarded Project Dates: June 1, 2011–
August 31, 2016.’’
5. On page 48035, second column, in
FR Doc. 2022–16867, thirteenth
paragraph, line 1, remove ‘‘Figure 6 of
UL1 TR000124.’’
Dated: September 13, 2022.
Wanda K. Jones,
Acting Director, Office of Research Integrity,
Office of the Assistant Secretary for Health.
[FR Doc. 2022–20070 Filed 9–15–22; 8:45 am]
BILLING CODE 4150–31–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Meeting of the Tick-Borne Disease
Working Group
Office of the Assistant
Secretary for Health, Office of the
Secretary, Department of Health and
Human Services.
ACTION: Notice.
AGENCY:
As required by the Federal
Advisory Committee Act, the
Department of Health and Human
Services (HHS) is hereby giving notice
that the Tick-Borne Disease Working
Group (TBDWG) will hold a meeting.
The meeting will be open to the public
via webcast. For this meeting, the
TBDWG will review and vote upon the
SUMMARY:
E:\FR\FM\16SEN1.SGM
16SEN1
khammond on DSKJM1Z7X2PROD with NOTICES
Federal Register / Vol. 87, No. 179 / Friday, September 16, 2022 / Notices
third and final Report to Congress and
the HHS Secretary. The 2022 report will
address a wide range of topics related to
tick-borne diseases, such as,
surveillance, prevention, diagnosis,
diagnostics, and treatment; identify
advances made in research, as well as
overlap and gaps in tick-borne disease
research; and provide recommendations
regarding any appropriate changes or
improvements to such activities and
research.
DATES: The public can view the meeting
online via webcast on October 25, 2022
from approximately 9:00 a.m. to 5:00
p.m. ET (times are tentative and subject
to change) each day. The confirmed
times and agenda items for the meeting
will be posted on the TBDWG web page
at https://www.hhs.gov/ash/advisorycommittees/tickbornedisease/meetings/
2022-10-25/ when this
information becomes available.
FOR FURTHER INFORMATION CONTACT:
James Berger, Designated Federal Officer
for the TBDWG; Office of Infectious
Disease and HIV/AIDS Policy, Office of
the Assistant Secretary for Health,
Department of Health and Human
Services, Tower Building, 1101 Wootton
Parkway, Rockville, MD 20852. Email:
tickbornedisease@hhs.gov. Phone: 202–
795–7608.
SUPPLEMENTARY INFORMATION: A link to
view the webcast can be found on the
meeting website at https://www.hhs.gov/
ash/advisory-committees/
tickbornedisease/meetings/2022-10-25/
index.html when it becomes available.
The public will have an opportunity to
present their views to the TBDWG orally
during the meeting’s public comment
session or by submitting a written
public comment. Comments should be
pertinent to the meeting discussion.
Persons who wish to provide verbal or
written public comment should review
instructions at https://www.hhs.gov/
ash/advisory-committees/
tickbornedisease/meetings/2022-10-25/
index.html and respond by midnight
October 17, 2022 ET. Verbal comments
will be limited to three minutes each to
accommodate as many speakers as
possible during the 30-minute session.
Written public comments will be
accessible to the public on the TBDWG
web page prior to the meeting.
Background and Authority: The TickBorne Disease Working Group was
established on August 10, 2017, in
accordance with section 2062 of the 21st
Century Cures Act, and the Federal
Advisory Committee Act, 5 U.S.C. app.,
as amended, to provide expertise and
review federal efforts related to all tickborne diseases, to help ensure
interagency coordination and minimize
VerDate Sep<11>2014
16:43 Sep 15, 2022
Jkt 256001
overlap, and to examine research
priorities. The TBDWG is required to
submit a report to the HHS Secretary
and Congress on their findings and any
recommendations for the federal
response to tick-borne disease every two
years.
Dated: September 8, 2022.
James J. Berger,
Designated Federal Officer, Tick-Borne
Disease Working Group, Office of Infectious
Disease and HIV/AIDS Policy.
[FR Doc. 2022–20088 Filed 9–15–22; 8:45 am]
BILLING CODE 4150–28–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Office of the Secretary; Notice of
Meeting
Pursuant to section 10(a) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of a
meeting of the National Science
Advisory Board for Biosecurity.
The meeting will be held as a virtual
meeting and is open to the public.
Individuals who plan to view the virtual
meeting and need special assistance or
other reasonable accommodations to
view the meeting should notify the
Contact Person listed below in advance
of the meeting. The meeting will be
videocast and can be accessed from the
NIH Videocasting and Podcasting
website (https://videocast.nih.gov/).
Name of Committee: National Science
Advisory Board for Biosecurity.
Date: September 21, 2022.
Time: 1:00 p.m. to 5:00 p.m.
Agenda: The National Science Advisory
Board for Biosecurity (NSABB) meeting will
include a progress update from the NSABB
Working Group to Review and Evaluate
Potential Pandemic Pathogen Care and
Oversight (PC3O) Policy, and stakeholder
engagement on topics related to the U.S.
Government policies for the Oversight of
Dual Use Research of Concern (DURC).
Place: National Institutes of Health, 6705
Rockledge Drive, Suite 630, Bethesda, MD
20892, (Virtual Meeting Link will be
available at https://osp.od.nih.gov/
biotechnology/national-science-advisoryboard-for-biosecurity-nsabb/#meetings).
Contact Person: Cari Young, ScM, Acting
Director, Division of Biosafety, Biosecurity,
and Emerging Biotechnology Policy, Office of
Science Policy, Office of the Director,
National Institutes of Health, 6705 Rockledge
Drive, Suite 630, Bethesda, MD 20892, (301)
594–3746, SciencePolicy@od.nih.gov.
To sign up to make an oral public comment
at the meeting, please send an email to the
Contact Person listed above at least one
business day prior to the meeting date. Once
all time slots are filled, only written
comments will be accepted. Any interested
PO 00000
Frm 00040
Fmt 4703
Sfmt 4703
56965
person may file written comments by
forwarding the statement to the Contact
Person listed on this notice at least one
business day prior to the meeting date. The
statement should include the name, address,
telephone number and, when applicable, the
business or professional affiliation of the
interested person. Other than name and
contact information, please do not include
any personally identifiable information or
any information that you do not wish to
make public. Proprietary, classified,
confidential, or sensitive information should
not be included in your comments. Please
note that any written comments NIH receives
may be posted unredacted to the Office of
Science Policy website.
Information is also available on the NIH
Office of Science Policy website: https://
osp.od.nih.gov/biotechnology/nationalscience-advisory-board-for-biosecuritynsabb/#meetings, where an agenda, link to
the webcast meeting, and any additional
information for the meeting will be posted
when available. Materials for this meeting
will be posted prior to the meeting. Please
check this website for updates.
This notice is being published less than 15
days prior to the meeting due to scheduling
difficulties.
Dated: September 13, 2022.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2022–20098 Filed 9–15–22; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Submission for OMB Review; 30-Day
Comment Request; The Clinical Trials
Reporting Program (CTRP) Database
(NCI)
AGENCY:
National Institutes of Health,
HHS.
ACTION:
Notice.
In compliance with the
Paperwork Reduction Act of 1995, the
National Institutes of Health (NIH) has
submitted to the Office of Management
and Budget (OMB) a request for review
and approval of the information
collection listed below.
DATES: Comments regarding this
information collection are best assured
of having their full effect if received
within 30 days of the date of this
publication.
ADDRESSES: Written comments and
recommendations for the proposed
information collection should be sent
within 30 days of publication of this
notice to www.reginfo.gov/public/do/
PRAMain. Find this particular
information collection by selecting
‘‘Currently under 30-day Review—Open
SUMMARY:
E:\FR\FM\16SEN1.SGM
16SEN1
]]>Agencies
[Federal Register Volume 87, Number 179 (Friday, September 16, 2022)]
[Notices]
[Pages 56964-56965]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-20088]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Meeting of the Tick-Borne Disease Working Group
AGENCY: Office of the Assistant Secretary for Health, Office of the
Secretary, Department of Health and Human Services.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: As required by the Federal Advisory Committee Act, the
Department of Health and Human Services (HHS) is hereby giving notice
that the Tick-Borne Disease Working Group (TBDWG) will hold a meeting.
The meeting will be open to the public via webcast. For this meeting,
the TBDWG will review and vote upon the
[[Page 56965]]
third and final Report to Congress and the HHS Secretary. The 2022
report will address a wide range of topics related to tick-borne
diseases, such as, surveillance, prevention, diagnosis, diagnostics,
and treatment; identify advances made in research, as well as overlap
and gaps in tick-borne disease research; and provide recommendations
regarding any appropriate changes or improvements to such activities
and research.
DATES: The public can view the meeting online via webcast on October
25, 2022 from approximately 9:00 a.m. to 5:00 p.m. ET (times are
tentative and subject to change) each day. The confirmed times and
agenda items for the meeting will be posted on the TBDWG web page at
https://www.hhs.gov/ash/advisory-committees/tickbornedisease/meetings/2022-10-25/ when this information becomes available.
FOR FURTHER INFORMATION CONTACT: James Berger, Designated Federal
Officer for the TBDWG; Office of Infectious Disease and HIV/AIDS
Policy, Office of the Assistant Secretary for Health, Department of
Health and Human Services, Tower Building, 1101 Wootton Parkway,
Rockville, MD 20852. Email: [email protected]. Phone: 202-795-
7608.
SUPPLEMENTARY INFORMATION: A link to view the webcast can be found on
the meeting website at https://www.hhs.gov/ash/advisory-committees/tickbornedisease/meetings/2022-10-25/ when it becomes
available. The public will have an opportunity to present their views
to the TBDWG orally during the meeting's public comment session or by
submitting a written public comment. Comments should be pertinent to
the meeting discussion. Persons who wish to provide verbal or written
public comment should review instructions at https://www.hhs.gov/ash/advisory-committees/tickbornedisease/meetings/2022-10-25/ and
respond by midnight October 17, 2022 ET. Verbal comments will be
limited to three minutes each to accommodate as many speakers as
possible during the 30-minute session. Written public comments will be
accessible to the public on the TBDWG web page prior to the meeting.
Background and Authority: The Tick-Borne Disease Working Group was
established on August 10, 2017, in accordance with section 2062 of the
21st Century Cures Act, and the Federal Advisory Committee Act, 5
U.S.C. app., as amended, to provide expertise and review federal
efforts related to all tick-borne diseases, to help ensure interagency
coordination and minimize overlap, and to examine research priorities.
The TBDWG is required to submit a report to the HHS Secretary and
Congress on their findings and any recommendations for the federal
response to tick-borne disease every two years.
Dated: September 8, 2022.
James J. Berger,
Designated Federal Officer, Tick-Borne Disease Working Group, Office of
Infectious Disease and HIV/AIDS Policy.
[FR Doc. 2022-20088 Filed 9-15-22; 8:45 am]
BILLING CODE 4150-28-P
